Stocks / NASDAQ / Heat Biologics, Inc.

Heat Biologics, Inc.

Industry:   Health Care - Major Pharmaceuticals Stock Symbol:   HTBX - NASDAQ Animal Usage:   Animal Testing

Our Opinion

Heat Biologics, Inc. is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.

Supporting Evidence:

The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.

“Animal studies have confirmed that our technology initiates a mechanism called cross-presentation that is critical to inducing tumor rejection. Importantly, it does this independently and successfully without additional CD4+ T cell recruitment, which is typically required in a normal immune system response. This is particularly important in cancer and HIV because helper T cell activity is frequently impaired in these disease states. “(Page 55) Read the full article

Company Description

Heat Biologics, Inc. operates as a clinical-stage biopharmaceutical company, with interest in the development of novel allergenic drugs. The company focuses on the commercialization of ImPact Therapy, a platform technology that offers a novel approach to treat cancer and other infectious diseases, including HIV, HCV and malaria by using live, genetically-modified, and irradiated human cells to activate the immune system against specific defined targets. Heat Biologics was founded on June 10, 2008 by Jeffrey Alan Wolf and is headquartered in Durham, NC. [Source: MarketWatch]

Company Website: http://www.heatbio.com

Contact:   http://www.heatbio.com/contact; IR: investorrelations@heatbio.com;